These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9738237)

  • 1. [Regulation of human DMD gene expression. An example of multiple utilization of genetic information].
    Napierała D; Słomski R
    Postepy Biochem; 1998; 44(1):48-55. PubMed ID: 9738237
    [No Abstract]   [Full Text] [Related]  

  • 2. [DMD gene--the largest human gene].
    Kwiatkowska J; Słomski R
    Postepy Biochem; 1992; 38(2):49-55. PubMed ID: 1461839
    [No Abstract]   [Full Text] [Related]  

  • 3. Screening for minor changes in the distal part of the human dystrophin gene in Greek DMD/BMD patients.
    Kekou K; Mavrou A; Florentin L; Youroukos S; Zafiriou DI; Skouteli HN; Metaxotou C
    Eur J Hum Genet; 1999; 7(2):179-87. PubMed ID: 10196701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional profiles from patients with dystrophinopathies and limb girdle muscular dystrophies as determined by qRT-PCR.
    Arning L; Jagiello P; Schara U; Vorgerd M; Dahmen N; Gencikova A; Mortier W; Epplen JT; Gencik M
    J Neurol; 2004 Jan; 251(1):72-8. PubMed ID: 14999492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothesis: the existence of embryonic and adult isoforms of mRNA dystrophin provides an explanation for unusual clinical findings.
    Zatz M; Passos-Bueno MR; Vainzof M; Pavanello RC
    Am J Med Genet; 1989 Mar; 32(3):438-41. PubMed ID: 2658593
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration.
    Bertoni C; Jarrahian S; Wheeler TM; Li Y; Olivares EC; Calos MP; Rando TA
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):419-24. PubMed ID: 16387861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current understanding of dystrophin-related muscular dystrophy and therapeutic challenges ahead.
    Zhou GQ; Xie HQ; Zhang SZ; Yang ZM
    Chin Med J (Engl); 2006 Aug; 119(16):1381-91. PubMed ID: 16934185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological strategies for muscular dystrophy.
    Khurana TS; Davies KE
    Nat Rev Drug Discov; 2003 May; 2(5):379-90. PubMed ID: 12750741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utrophin promoter A drives high expression of the transgenic LacZ gene in liver, testis, colon, submandibular gland, and small intestine.
    Takahashi J; Itoh Y; Fujimori K; Imamura M; Wakayama Y; Miyagoe-Suzuki Y; Takeda S
    J Gene Med; 2005 Feb; 7(2):237-48. PubMed ID: 15538725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
    Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
    Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular cloning and protein expression of Duchenne muscular dystrophy gene products in porcine retina.
    Bordais A; Bolaños-Jimenez F; Fort P; Varela C; Sahel JA; Picaud S; Rendon A
    Neuromuscul Disord; 2005 Jul; 15(7):476-87. PubMed ID: 15941659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of three novel mutations in the dystrophin gene detected by the heteroduplex/SSCA screening procedure. Mutations in brief no. 222. Online.
    Dubourg C; Odent S; Fergelot P; Le Gall JY; David V; Blayau M
    Hum Mutat; 1999; 13(2):173. PubMed ID: 10094565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential expression of genes involved in muscular dystrophies during human development.
    Durand M; Suel L; Barbet JP; Beckmann JS; Fougerousse F
    Morphologie; 2002 Jun; 86(273):9-12. PubMed ID: 12224393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGD for dystrophin gene deletions using fluorescence in situ hybridization.
    Malmgren H; White I; Johansson S; Levkov L; Iwarsson E; Fridström M; Blennow E
    Mol Hum Reprod; 2006 May; 12(5):353-6. PubMed ID: 16608904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Genotypic diagnosis of Duchenne and Becker muscular dystrophies].
    Tuffery-Giraud S; Chambert S; Demaille J; Claustres M
    Ann Biol Clin (Paris); 1999; 57(4):417-26. PubMed ID: 10432364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ERG phenotype of a dystrophin mutation in heterozygous female carriers of Duchenne muscular dystrophy.
    Fitzgerald KM; Cibis GW; Gettel AH; Rinaldi R; Harris DJ; White RA
    J Med Genet; 1999 Apr; 36(4):316-22. PubMed ID: 10227401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy.
    Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S
    Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
    Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
    Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Large in-frame deletions of the rod-shaped domain of the dystrophin gene resulting in severe phenotype.
    Nevo Y; Muntoni F; Sewry C; Legum C; Kutai M; Harel S; Dubowitz V
    Isr Med Assoc J; 2003 Feb; 5(2):94-7. PubMed ID: 12674656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular therapy of muscular dystrophy].
    Takeda S
    Rinsho Shinkeigaku; 2000 Dec; 40(12):1267-9. PubMed ID: 11464475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.